Biocon, the Bengaluru-headquartered bio-pharma firm and the parent company for Biocon Biologics, has has been recognised as the ASIA IP ELITE for the fourth year in a row. Biocon’s subsidiary received this award at the recently concluded IP Business Congress Asia in Tokyo, Japan. Biocon Biologics has a product pipeline of 28 molecules.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OhXiVZ
via IFTTT
0 comments:
Post a Comment